MYRIAD GENETICS, INC. Increase (Decrease) in Other Noncurrent Assets
MYRIAD GENETICS, INC. (MYGN) reported Increase (Decrease) in Other Noncurrent Assets of $300.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-07-31
- MYRIAD GENETICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$200.00K, a 120.00% decline year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $500.00K.
- MYRIAD GENETICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$700.00K.
- MYRIAD GENETICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$1.80M, a 300.00% decline year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$2.00M.
- MYRIAD GENETICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00.
- MYRIAD GENETICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$600.00K, a 166.67% decline from fiscal 2022.
- MYRIAD GENETICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $900.00K, a 75.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $300.00K 10-Q · filed 2026-07-31 | -$400.00K derived: sum of 3 quarters · filed 2026-07-31 | -$2.20M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-06 | -$200.00K derived: sum of 2 quarters · filed 2026-05-06 | -$2.00M derived: sum of 3 quarters · filed 2026-05-06 | -$1.00M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-12-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$2.50M derived: sum of 2 quarters · filed 2026-02-24 | -$1.50M derived: sum of 3 quarters · filed 2026-07-31 | -$2.00M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$800.00K derived: sum of 2 quarters · filed 2026-07-31 | -$1.30M 10-Q · filed 2025-11-04 | -$1.50M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $500.00K 10-Q · filed 2026-07-31 | -$700.00K 10-Q · filed 2025-08-06 | $300.00K derived: sum of 3 quarters · filed 2026-07-31 | $1.20M derived: sum of 4 quarters · filed 2026-07-31 | ||
| 2025-03-31 | -$500.00K 10-Q · filed 2026-05-06 | -$700.00K derived: sum of 2 quarters · filed 2026-05-06 | $200.00K derived: sum of 3 quarters · filed 2026-05-06 | -$300.00K derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $700.00K derived: sum of 2 quarters · filed 2026-02-24 | $200.00K derived: sum of 3 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $400.00K derived: sum of 2 quarters · filed 2025-11-04 | $200.00K 10-Q · filed 2025-11-04 | -$600.00K derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$700.00K 10-Q · filed 2025-08-06 | -$1.50M derived: sum of 3 quarters · filed 2026-02-24 | -$6.40M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | -$200.00K 10-Q · filed 2025-05-07 | -$1.00M derived: sum of 2 quarters · filed 2026-02-24 | -$5.90M derived: sum of 3 quarters · filed 2026-02-24 | -$3.10M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$5.70M derived: sum of 2 quarters · filed 2026-02-24 | -$2.90M derived: sum of 3 quarters · filed 2026-02-24 | -$600.00K 10-K · filed 2026-02-24 | |||
| 2023-09-30 | -$4.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$2.10M derived: sum of 2 quarters · filed 2024-11-08 | $200.00K 10-Q · filed 2024-11-08 | $200.00K derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.10M 10-Q · filed 2024-08-07 | $5.10M derived: sum of 3 quarters · filed 2025-02-28 | $5.60M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | $2.30M 10-Q · filed 2024-05-08 | $2.30M derived: sum of 2 quarters · filed 2025-02-28 | $2.80M derived: sum of 3 quarters · filed 2025-02-28 | $2.90M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $500.00K derived: sum of 2 quarters · filed 2025-02-28 | $600.00K derived: sum of 3 quarters · filed 2025-02-28 | $900.00K 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $600.00K derived: sum of 2 quarters · filed 2023-11-07 | $900.00K 10-Q · filed 2023-11-07 | $500.00K 10-Q · filed 2022-11-02 | $900.00K derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $400.00K 10-Q · filed 2023-08-04 | $1.00M 10-Q · filed 2022-08-05 | $400.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.30M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-04 | $300.00K derived: sum of 2 quarters · filed 2024-02-28 | $1.20M derived: sum of 3 quarters · filed 2024-02-28 | $2.70M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $900.00K derived: sum of 2 quarters · filed 2024-02-28 | $2.40M derived: sum of 3 quarters · filed 2024-02-28 | $3.60M 10-K · filed 2024-02-28 | $4.00M 10-K · filed 2022-02-25 | ||
| 2021-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $2.40M derived: sum of 2 quarters · filed 2022-11-02 | $3.60M 10-Q · filed 2022-11-02 | $4.70M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $2.70M 10-Q · filed 2022-08-05 | $3.80M derived: sum of 3 quarters · filed 2023-03-01 | $5.00M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $1.20M 10-Q · filed 2022-05-06 | $2.30M derived: sum of 2 quarters · filed 2023-03-01 | $3.50M derived: sum of 3 quarters · filed 2023-03-01 | $3.50M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $1.10M derived: 10-K 6 month − 10-Q 3 month · filed 2023-03-01 | $2.30M 10-K · filed 2023-03-01 | $2.30M derived: sum of 3 quarters · filed 2023-03-01 | $2.30M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-09-30 | $1.20M 10-Q · filed 2020-11-09 | $1.20M derived: sum of 2 quarters · filed 2021-08-04 | $1.20M 10-Q · filed 2021-11-04 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $0.00 10-Q · filed 2021-08-04 | $0.00 10-K · filed 2023-03-01 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-05 | ||||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | $0.00 10-K · filed 2022-02-25 | ||||||
| 2018-06-30 | $0.00 10-KT · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |